Abvc Biopharma (ABVC) EBITDA Margin (2010 - 2024)
Abvc Biopharma's EBITDA Margin came in at -22423.39% for FY2025, down 21506.33 percentage points from -917.06% in FY2024.
Powered by 
Analysis
Abvc Biopharma (ABVC) EBITDA Margin (2010 - 2024) Analysis & Trends
Going back to FY2010, Abvc Biopharma's EBITDA Margin data covers 10 years.
- EBITDA Margin carries a five-year change of -20670.21 percentage points (FY2020 to FY2025).
- The FY2025 figure represents the lowest annual EBITDA Margin since FY2018.
- Per Business Quant, earlier years put EBITDA Margin at -917.06% in FY2024 (+3503.47 pp), -4420.52% in FY2023 (-2864.44 pp), -1556.08% in FY2022 (+1730.62 pp) and -3286.70% in FY2021 (-1533.52 pp).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 39.10% |
| 10 | Abvc Biopharma | 27.31 Mn | 29.30 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | -35,307.43% |
| Sep 30, 2024 | -70.31% |
| Jun 30, 2024 | -722.89% |
| Mar 31, 2024 | -235,433.11% |
| Dec 31, 2023 | -23,291.13% |
| Sep 30, 2023 | -13,519.35% |
| Jun 30, 2023 | -35,797.10% |
| Mar 31, 2023 | -1,480.99% |
| Dec 31, 2022 | -530.83% |
| Sep 30, 2022 | -8,775.65% |
| Jun 30, 2022 | -652.49% |
| Mar 31, 2022 | -24,213.99% |
| Sep 30, 2021 | -1,987.59% |
| Jun 30, 2021 | -6,464.72% |
| Mar 31, 2021 | -474.94% |
| Dec 31, 2020 | -7,788.35% |
| Sep 30, 2020 | -1,108.61% |
| Jun 30, 2020 | -522.53% |
| Mar 31, 2020 | -1,472.60% |
| Dec 31, 2019 | -1,113.01% |
API Access
Abvc Biopharma EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ABVC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "ABVC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ABVC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();